SCHEMBL10501361

SCHEMBL10501361

Cc1ccc(F)cc1-n1[se]c2ccccc2c1=S

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MPI P34949 2/20 0.51
▸ PHOSPHO1 Q8TCT1 1/20 0.51
▸ METAP2 P50579 7/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ G6PD P11413 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ APOBEC3G Q9HC16 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10501742 0.89 METAP2 (0.47) MPIPHOSPHO1METAP2
SCHEMBL10502376 0.85 MPI (0.69) MPIPHOSPHO1METAP2KDM4EALDH1A1
SCHEMBL10501803 0.83 MPI (0.74) MPIPHOSPHO1METAP2
SCHEMBL10501413 0.83 MPI (0.51) MPIPHOSPHO1METAP2ALDH1A1LMNA
SCHEMBL10501811 0.82 MPI (0.48) MPIPHOSPHO1METAP2L3MBTL1KDM4E
SCHEMBL10501265 0.78 MPI (0.49) MPIPHOSPHO1METAP2L3MBTL1ALDH1A1
SCHEMBL10501678 0.77 METAP2 (0.49) MPIPHOSPHO1METAP2
SCHEMBL10501498 0.77 METAP2 (0.43) MPIPHOSPHO1METAP2KDM4EALDH1A1
SCHEMBL10501645 0.77 MPI (0.54) MPIPHOSPHO1METAP2KDM4EALDH1A1
SCHEMBL10502354 0.75 METAP2 (0.41) MPIPHOSPHO1METAP2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0154851-B1 BENZISOSELENAZOLETHIONES,PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PRODUCTS CONTAINING THESE COMPOUNDS A. Nattermann & Cie. GmbH (DE) 1989-08-02 — — EP disclosed
US-4711961-A Benzisoselenazolethiones and process for the treatment of various diseases in humans A. NATTERMANN & CIE GMBH (DE) 1987-12-08 — — US disclosed
EP-0154851-A1 Benzisoselenazolethiones,process for their preparation and pharmaceutical products containing these compounds A. Nattermann & Cie. GmbH (DE) 1985-09-18 — — EP disclosed
Send feedback